EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Review of Therapeutic Strategies against Cardiac Fibrosis: From Classical Pharmacology to Novel Molecular, Epigenetic, and Biotechnological Approaches

Erica Floris, Claudia Cozzolino, Sangar Marconi, Fabiana Tonicello, Vittorio Picchio, Francesca Pagano, Isotta Chimenti

Reviews in Cardiovascular Medicine · 08.08.2023 · 24 (8)

DOI: 10.31083/j.rcm2408226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 08.08.2023. Verfasst von Erica Floris und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Surgical Sciences and Biotechnologies, Sapienza University, 04100 Latina, Italy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza University of Rome, Italian Health Ministry, Regione Lazio.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases are the first cause of death worldwide, with a heavy social and economic impact. They include a wide range of pathological conditions, among which cardiac fibrosis represents a common pathogenetic hallmark. The fibrotic process is driven by cardiac mesenchymal stromal cells, namely fibroblasts, which become activated, proliferate, and differentiate into myofibroblasts in response to several stimuli, in the end secreting extracellular matrix proteins, and mediating cardiac tissue remodelling and stiffening. A specific therapy for the exclusive treatment of cardiac fibrosis is still lacking. Given the growing quest for reducing the burden of cardiovascular diseases, there is increasing interest in the search for new effective anti-fibrotic therapies. In this review, we will briefly summarize the limited pharmacological therapies known to act, at least in part, against cardiac fibrosis. Then we will present novel potential active molecules, molecular targets, and biotechnological approaches emerged in the last decade, as possible future therapeutic strategies for cardiac fibrosis, with a specific focus on targeting fibroblast activation and function.

Schlagwörter

Stichwörter der Autor:innen

RNA-therapeuticsbiological therapiescardiac fibroblastscardiac fibrosiscardiac remodelingcardiac stromal cellsnon-coding RNAsprecision medicine

Autor:innen und Institutionen

  • Department of Medical Surgical Sciences and Biotechnologies, Sapienza University, 04100 Latina, Italy.
  • Institute of Biochemistry and Cell Biology, National Council of Research (IBBC-CNR), 00015 Monterotondo, Italy.
  • Mediterranea Cardiocentro, 80122 Napoli, Italy.

Förderung

  • Sapienza University of Rome
  • Italian Health Ministry
  • Regione Lazio

Zitieren

APA

Floris, E., Cozzolino, C., Marconi, S., Tonicello, F., Picchio, V., Pagano, F., & Chimenti, I. (2023). A Review of Therapeutic Strategies against Cardiac Fibrosis: From Classical Pharmacology to Novel Molecular, Epigenetic, and Biotechnological Approaches. Reviews in Cardiovascular Medicine, 24(8). https://doi.org/10.31083/j.rcm2408226

Vancouver

Floris E, Cozzolino C, Marconi S, Tonicello F, Picchio V, Pagano F, et al. A Review of Therapeutic Strategies against Cardiac Fibrosis: From Classical Pharmacology to Novel Molecular, Epigenetic, and Biotechnological Approaches. Reviews in Cardiovascular Medicine. 2023;24(8). doi:10.31083/j.rcm2408226

BibTeX
@article{Floris2023,
  author = {Floris, Erica and Cozzolino, Claudia and Marconi, Sangar and Tonicello, Fabiana and Picchio, Vittorio and Pagano, Francesca and Chimenti, Isotta},
  title = {A Review of Therapeutic Strategies against Cardiac Fibrosis: From Classical Pharmacology to Novel Molecular, Epigenetic, and Biotechnological Approaches},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2023},
  volume = {24},
  number = {8},
  doi = {10.31083/j.rcm2408226}
}
Kostenlos starten →